Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,791 | 10 | 74.4% |
| Food and Beverage | $959.76 | 75 | 25.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,845 | 13 | $0 (2021) |
| PFIZER INC. | $202.86 | 22 | $0 (2020) |
| Merz North America, Inc. | $132.92 | 9 | $0 (2019) |
| Novo Nordisk Inc | $98.13 | 7 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $88.74 | 6 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $77.37 | 6 | $0 (2020) |
| Allergan Inc. | $43.01 | 3 | $0 (2019) |
| ABBVIE INC. | $42.88 | 2 | $0 (2022) |
| Sanofi Pasteur Inc. | $32.65 | 2 | $0 (2018) |
| Kowa Pharmaceuticals America, Inc. | $25.23 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $21.50 | 1 | ABBVIE INC. ($21.50) |
| 2021 | $2,812 | 11 | Novartis Pharmaceuticals Corporation ($2,791) |
| 2020 | $120.89 | 8 | PFIZER INC. ($57.94) |
| 2019 | $432.46 | 37 | Merz North America, Inc. ($122.43) |
| 2018 | $180.68 | 13 | Sanofi Pasteur Inc. ($32.65) |
| 2017 | $182.85 | 15 | Novo Nordisk Inc ($37.63) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/19/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $141.12 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $178.64 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $76.93 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $10.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $9.25 | General |
| Category: NEUROSCIENCE | ||||||
| 06/16/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Cardiovascular | ||||||
| 03/25/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/26/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/12/2020 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: VACCINES | ||||||
| 02/05/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/22/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/22/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/09/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: GASTROINTESTINAL | ||||||
| 12/11/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $0.77 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/29/2019 | Merz North America, Inc. | — | Food and Beverage | Cash or cash equivalent | $14.74 | General |
| 11/22/2019 | Merz North America, Inc. | — | Food and Beverage | Cash or cash equivalent | $19.49 | General |
| 11/22/2019 | Merz North America, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.25 | General |
| 11/22/2019 | Merz North America, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 7 | 293 | 310 | $43,423 | $13,264 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 37 | 37 | $8,473 | $4,204 | 49.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 69 | 76 | $11,172 | $3,349 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 99 | 104 | $15,392 | $2,470 | 16.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 32 | $3,392 | $1,353 | 39.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 11 | $2,343 | $810.90 | 34.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 33 | 33 | $1,155 | $581.94 | 50.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 15 | 17 | $1,496 | $495.00 | 33.1% |
About Dr. Thomas Cox, MD
Dr. Thomas Cox, MD is a Family Medicine healthcare provider based in Holland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1235138181.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Cox, MD has received a total of $3,751 in payments from pharmaceutical and medical device companies, with $21.50 received in 2022. These payments were reported across 85 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($2,791).
As a Medicare-enrolled provider, Cox has provided services to 293 Medicare beneficiaries, totaling 310 services with total Medicare billing of $13,264. Data is available for 1 year (2020–2020), covering 7 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Holland, OH
- Active Since 07/21/2005
- Last Updated 08/27/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235138181
Products in Payments
- GILENYA (Drug) $2,791
- CHANTIX (Drug) $102.32
- JANUVIA (Drug) $77.37
- VRAYLAR (Drug) $64.39
- XARELTO (Drug) $62.64
- ENTRESTO (Drug) $54.51
- PREVNAR - 13 (Biological) $52.20
- Tresiba (Drug) $48.16
- MENACTRA (Drug) $32.65
- Vascepa (Drug) $29.33
- INVOKANA (Drug) $26.10
- Victoza (Drug) $25.11
- AJOVY (Drug) $24.29
- LYRICA (Drug) $23.04
- UBRELVY (Drug) $21.50
- Trintellix (Drug) $21.21
- Axium INS DRG IPG (Device) $20.91
- XIFAXAN (Drug) $16.53
- Livalo (Drug) $14.09
- BEVESPI AEROSPHERE (Drug) $13.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Holland
Dr. Laurie Birkholz, Md, MD
Family Medicine — Payments: $44,560
Dr. Nicholas Lopez, M.d, M.D
Family Medicine — Payments: $16,018
Yasser Malik, Md, MD
Family Medicine — Payments: $13,095
Jack Derks, Md, MD
Family Medicine — Payments: $5,436
Dr. Yelena Isayenko, M.d, M.D
Family Medicine — Payments: $5,284
Dr. Ryan Flamion, Md, MD
Family Medicine — Payments: $4,279